Boothbay Fund Management, LLC Vanda Pharmaceuticals Inc. Transaction History

Boothbay Fund Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$9.32 - $12.02 $2.78 Million - $3.59 Million	-298,605 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$9.66 - $12.02 $198,078 - $246,470	20,505 Added 7.37%	298,605 $3.42 Million
Q1 2020 May 15, 2020	BUY	$7.5 - $16.8 $975,750 - $2.19 Million	130,100 Added 87.91%	278,100 $2.88 Million
Q4 2019 Feb 14, 2020	SELL	$12.38 - $17.47 $14,100 - $19,898	-1,139 Reduced 0.76%	148,000 $2.43 Million
Q3 2019 Nov 14, 2019	BUY	$12.27 - $15.79 $345,290 - $444,346	28,141 Added 23.26%	149,139 $1.98 Million
Q2 2019 Aug 14, 2019	BUY	$13.37 - $18.85 $1.14 Million - $1.6 Million	85,064 Added 236.72%	120,998 $1.71 Million
Q1 2019 May 15, 2019	BUY	$17.59 - $31.05 $460,347 - $812,609	26,171 Added 268.06%	35,934 $661,000
Q4 2018 Feb 14, 2019	BUY	$18.97 - $31.47 $185,204 - $307,241	9,763 New	9,763 $255,000
Q2 2018 Aug 14, 2018	SELL	$13.95 - $19.15 $269,876 - $370,475	-19,346 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$14.05 - $20.2 $271,811 - $390,789	19,346 New	19,346 $326,000

153

44.9M

132K

220K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $277M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.